MedTrace Logo

The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT)

NCT04399070 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2020-07-22

No results posted yet for this study

Summary

This study will determine the effectiveness and safety of S-Ketamine in depression patients undergoing electroconvulsive therapy.

Conditions

Interventions

DRUG

S-ketamine

The depression patients received propofol and S-ketamine before ECT

DRUG

ketamine

The depression patients received propofol and ketamine before ECT

DRUG

saline

The depression patients received propofol and saline before ECT

Sponsors & Collaborators

  • Yan Qiu

    lead OTHER

Principal Investigators

  • Guizhi Du, Doctor · West China Hospital of Sichuan University, Department of Anesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2020-12-30
Completion
2021-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04399070 on ClinicalTrials.gov